Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis Subjects Who Have Achieved a Stable Low Disease Activity-state (DOSERA)

NCT00858780 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00858780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00858780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis Subjects Who Have Achieved a Stable Low Disease Activity-state (DOSERA)
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
June 30, 2012
Enrollment
91 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis